{"id":3530,"date":"2025-09-05T16:34:14","date_gmt":"2025-09-05T07:34:14","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3530"},"modified":"2025-09-05T16:34:15","modified_gmt":"2025-09-05T07:34:15","slug":"%e5%af%ba%e7%94%b0%e3%80%80%e5%8f%82%e7%9c%81","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3530","title":{"rendered":"Mitsumi Terada EN"},"template":"","class_list":["post-3530","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Mitsumi Terada","familyName_eg":"Terada","has_jp_name":true,"name_jp":"\u5bfa\u7530 \u53c2\u7701","researcher_photo":2068,"participated_in":["-1"],"degree":"MD, PhD","position":"Dept. of International Clinical Development, General Manager of Asian Partnerships Office","eg_position":"Dept. of International Clinical Development, General Manager of Asian Partnerships Office","facilities":3399,"department":["36"],"speciality":"","eg_speciality":"","background":"

Dr. TERADA's story<\/h2>\r\n

Dr. Terada graduated with his MD from the Jikei University in 2009 and obtained PhD in 2019.
\r\nFrom 2011 to 2016, he worked as a surgeon for gastrointestinal cancer, especially for gastric cancer from 2014. He joined the EORTC in 2017 as a medical research fellow and learned methodology of international clinical trials on European basis. At the EORTC, he proposed and organized some collaborative projects and events between JCOG (Japan Clinical Oncology Group) and EORTC, which let him realize how important and significant the international collaboration is. He is also interested in PRO\/QOL research for cancer patients and a chief investigator of an international collaborative study to update the EORTC QLQ STO22 that is QOL questionnaire for gastric cancer.
\r\nIn 2019, he was mainly involved in the establishment of Asian Partnerships Office (APO) in Bangkok, Thailand under the ATLAS project and appointed General Manager of APO in September 2021. He resides in Bangkok from December 2021, and will contribute to development of the partnerships with multiple stakeholders and establishment of governance structure for the ATLAS network.<\/p>\r\n

Research Interest<\/h2>\r\n

Clinical trial methodology, PRO\/QOL research for cancer patinets<\/p>\r\n

Professional Experience<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Sep 2021-present<\/td>\r\nGeneral Manager, Asian Partnerships Office, Department of International Clinical Development, NCCH, Japan<\/td>\r\n<\/tr>\r\n
Jun 2019-present<\/td>\r\nMedical staff, International Trials Management Section, NCCH, Japan<\/td>\r\n<\/tr>\r\n
Jun 2017-May 2019<\/td>\r\nMedical Research Fellow (Medical Department), EORTC HQ, and Clinical Research Fellow (International Trials Management Section), JCOG\/NCCH Japan<\/td>\r\n<\/tr>\r\n
Oct 2016-May 2017<\/td>\r\nClinical Research Resident, Japan Clinical Oncology Group (JCOG)<\/td>\r\n<\/tr>\r\n
Apr 2014-Sep 2016<\/td>\r\nResident (Gastric surgery) National Cancer Center Hospital East, Chiba, Japan<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","eg_background":"

Dr. TERADA's story<\/h2>\r\n

Dr. Terada graduated with his MD from the Jikei University in 2009 and obtained PhD in 2019.
\r\nFrom 2011 to 2016, he worked as a surgeon for gastrointestinal cancer, especially for gastric cancer from 2014. He joined the EORTC in 2017 as a medical research fellow and learned methodology of international clinical trials on European basis. At the EORTC, he proposed and organized some collaborative projects and events between JCOG (Japan Clinical Oncology Group) and EORTC, which let him realize how important and significant the international collaboration is. He is also interested in PRO\/QOL research for cancer patients and a chief investigator of an international collaborative study to update the EORTC QLQ STO22 that is QOL questionnaire for gastric cancer.
\r\nIn 2019, he was mainly involved in the establishment of Asian Partnerships Office (APO) in Bangkok, Thailand under the ATLAS project and appointed General Manager of APO in September 2021. He resides in Bangkok from December 2021, and will contribute to development of the partnerships with multiple stakeholders and establishment of governance structure for the ATLAS network.<\/p>\r\n

Research Interest<\/h2>\r\n

Clinical trial methodology, PRO\/QOL research for cancer patinets<\/p>\r\n

Professional Experience<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Sep 2021-present<\/td>\r\nGeneral Manager, Asian Partnerships Office, Department of International Clinical Development, NCCH, Japan<\/td>\r\n<\/tr>\r\n
Jun 2019-present<\/td>\r\nMedical staff, International Trials Management Section, NCCH, Japan<\/td>\r\n<\/tr>\r\n
Jun 2017-May 2019<\/td>\r\nMedical Research Fellow (Medical Department), EORTC HQ, and Clinical Research Fellow (International Trials Management Section), JCOG\/NCCH Japan<\/td>\r\n<\/tr>\r\n
Oct 2016-May 2017<\/td>\r\nClinical Research Resident, Japan Clinical Oncology Group (JCOG)<\/td>\r\n<\/tr>\r\n
Apr 2014-Sep 2016<\/td>\r\nResident (Gastric surgery) National Cancer Center Hospital East, Chiba, Japan<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n

 <\/p>\r\n

 <\/p>","researcher_outerlink1":"https:\/\/www.eortc.org\/","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3399"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}